St. Louis CyberKnife is proud to commemorate the 20th anniversary of CyberKnifeÂ® technology this year. Developed in 1994 at Stanford by Dr. John Adler, the concept was conceived with the goal of treating tumors throughout the body with radiosurgery, a treatment that at the time was restricted to head and neck tumors.
Officially approved by the U.S. Food and Drug Administration in 2001, the technology has been adopted globally for the treatment of benign and malignant tumors in the head, neck and body. CyberKnife manufacturer, Accuray, reports that the system has been used in 40 countries to treat more than half a million patients to date.
Over the last two decades, CyberKnife treatment has evolved with expanded applications and the availability of long-term patient results to further demonstrate its efficacy. Most recently the American Society for Radiation Oncology endorsed CyberKnife as a first line treatment option for prostate cancer.
St. LouisÂ CyberKnife has been a proud provider ofÂ CyberKnife treatment since its opening. Lung tumors, brain tumors and prostate cancer are among our center’s most frequently treated diseases.Â
This is not intended as medical advice to replace the expertise and judgment of your health care team. It is intended to help you and your family make informed decisions, together with your doctor.